LORBREXEN 100MG LORLATINIB

उत्पाद वर्णन

Lorbrexen 100mg tablet is used to treat non-small cell lung cancer. Lorbrexen is used in patients whose tumors are ALK-positive (Anaplastic lymphoma kinase) and detected in FDA-approved tests. Lorbrexen helps in reducing the cancer cells in the patients body. This medicine is very effective and the benefits will be seen soon if patients follow the doctors prescription strictly. During treatment with this medicine if the patient faces any type of issues after the beginning of treatment rather than regular days inform your doctor.

Pharmacodynamics

Lorbrexen 100mg tablet is a third-generation ALK tyrosine kinase inhibitor. It blocks the ALK protein, which is responsible for the growth of cancer cells in the body. In studies, Lorlatinib has shown an effective against a variety of ALK-positive tumors and resists other ALK TKIs. It may take a few weeks or months to show benefits if strictly follow the doctors prescription. However, at the beginning of treatment discuss with the doctor all the benefits and risks.